Ed Kaye, former CEO of Sarepta Therapeutics, is stepping down from his current role as chief executive of a Boston-area ...

The administration’s bombing campaign against the Iran-backed group is running up against America's political and industrial ...

Shares of Stoke Therapeutics sank Tuesday as the drugmaker said its CEO Dr. Edward Kaye is stepping down from his role.

George Weaver joins BBC Radio Stoke's Lucas Yeomans to discuss the Potters' last-gasp defeat by Millwall at The Den.

Follow live coverage as Millwall face Stoke City in the Championship today. An increasingly competitive second tier in ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $28.0, a high estimate of $47.00 ...

This is Millwall manager Alex Neil's first league meeting with former club Stoke since he left in December 2023. Neil has won ...

Stoke Therapeutics' chief executive, Edward Kaye, is stepping down after more than seven years at the helm of the biotechnology company. Stoke on Tuesday said Ian Smith, a board member since September ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational ...

Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers ...